Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.
Saved in:
| Title: | Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. |
|---|---|
| Authors: | Bedir, Şahin1 (AUTHOR) sahinbedir7786@hotmail.com, Kapagan, Tanju2 (AUTHOR), Çakan Demirel, Burçin3 (AUTHOR), Tokocin, Merve4 (AUTHOR), Yıldırım, Çiğdem5 (AUTHOR), Taş, Semra6 (AUTHOR), Bozkaya, Yakup1 (AUTHOR), Oyman, Abdilkerim1,2 (AUTHOR), Bulut, Nilufer2,3 (AUTHOR), Erdem, Gökmen Umut2,4 (AUTHOR) |
| Source: | Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 5, p1898. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
